Adaptive Biotechnologies (ADPT) Interest Expenses (2022 - 2026)

Adaptive Biotechnologies has disclosed Interest Expenses across 5 years of filings, most recently posting $2.7 million for Q2 2026.

• In Q2 2026, Interest Expenses fell 8.62% year-over-year to $2.7 million; the TTM figure through Jun 2026 stood at $11.5 million (down 2.01% YoY), while the FY2025 annual figure was $11.8 million, up 1.71% from the prior year.
• Interest Expenses came in at $2.7 million for Q2 2026 at Adaptive Biotechnologies, down from $2.9 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $3.7 million in Q3 2023 to a low of $653000.0 in Q3 2022.
• Average Interest Expenses over 5 years is $2.9 million, with a median of $3.0 million recorded in 2024.
• Year-over-year, Interest Expenses surged 459.26% in 2023 and declined 25.21% in 2024.
• Over 5 years, Interest Expenses stood at $3.6 million in 2022, then dropped by 15.98% to $3.0 million in 2023, then retreated by 1.99% to $3.0 million in 2024, then gained by 0.07% to $3.0 million in 2025, then dropped by 8.8% to $2.7 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $2.7 million in Q2 2026, $2.9 million in Q1 2026, and $3.0 million in Q4 2025.